Application 019668
- Type
- NDA
- Sponsor
- PFIZER
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CARDURA | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 1MG BASE | Yes | Yes |
| 002 | CARDURA | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 2MG BASE | Yes | No |
| 003 | CARDURA | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 4MG BASE | Yes | No |
| 004 | CARDURA | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 8MG BASE | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019668-001 | CARDURA | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 |
| N019668-002 | CARDURA | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 |
| N019668-003 | CARDURA | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 |
| N019668-004 | CARDURA | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N019668-001 | AB |
| N019668-002 | AB |
| N019668-003 | AB |
| N019668-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-001 | CARDURA | EQ 1MG BASE | TABLET / ORAL | AB | RLD, RS | 1990-11-02 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-002 | CARDURA | EQ 2MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-003 | CARDURA | EQ 4MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-004 | CARDURA | EQ 8MG BASE | TABLET / ORAL | AB | RLD | 1990-11-02 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N019668-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019668-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019668-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019668-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019668-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N019668-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019668-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019668-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019668-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019668-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019668-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019668-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N019668-004 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 445dc831-1960-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings, Adverse reactions | 019668 NDA019668 |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 3ab222b7-74cc-5343-e063-6294a90a9616 | 2025-07-24 | Warnings, Adverse reactions | 019668 NDA019668 |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Mylan Pharmaceuticals Inc. | 2e524986-7903-416f-b2b8-d27295103e75 | 2024-03-11 | Warnings, Adverse reactions | 019668 NDA019668 |
| Cardura | DOXAZOSIN | Viatris Specialty LLC | 5e1f5e49-2da1-43ab-9795-228a8bcc5a82 | 2023-10-15 | Warnings, Adverse reactions | 019668 NDA019668 |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | b364c7a8-72b5-4776-a500-400c37a72c9b | 2022-02-03 | Warnings, Adverse reactions | 019668 NDA019668 |
| Doxazosin | DOXAZOSIN | Mylan Pharmaceuticals Inc. | 6b887aa5-5edf-48c5-a480-dea8c35afa9d | 2022-01-20 | Warnings, Adverse reactions | 019668 NDA019668 59762-2380 59762-2310 59762-2320 59762-2410 59762-2340 |
| Cardura | DOXAZOSIN | ROERIG | eefc47bc-c10f-49bb-8ef7-5999f798ab39 | 2022-01-20 | Warnings, Adverse reactions | 019668 NDA019668 0049-2750 0049-2512 0049-2770 0049-2760 0049-2780 0049-2410 0049-2614 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0049-2410 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2410 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2410 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2512 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2512 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2512 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2614 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2614 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2614 | Cardura | doxazosin | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2750 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2760 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2770 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 0049-2780 | Cardura | doxazosin mesylate | Roerig | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2310 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2320 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2340 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2380 | Doxazosin mesylate | doxazosin mesylate | Greenstone LLC | NDA | Current |
| 59762-2410 | Doxazosin | doxazosin | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2410 | Doxazosin | doxazosin | Greenstone LLC | NDA AUTHORIZED GENERIC | Current |
| 59762-2410 | Doxazosin | doxazosin | Greenstone LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68463 | SUPPL | 2021-08-25 |
| 67895 | SUPPL | 2021-06-24 |
| 11617 | SUPPL | 2016-06-13 |
| 1482 | SUPPL | 2016-06-10 |
| 11615 | SUPPL | 2015-08-24 |
| 11616 | SUPPL | 2013-11-08 |
| 17541 | SUPPL | 2013-11-07 |
| 17540 | SUPPL | 2010-03-10 |
| 33850 | SUPPL | 2009-07-23 |
| 17539 | SUPPL | 2009-07-17 |
| 1481 | SUPPL | 2006-03-03 |
| 17538 | SUPPL | 2003-06-22 |
| 1480 | SUPPL | 2002-01-23 |